ARTICLE | Distillery Therapeutics
Therapeutics: Nuclear factor of activated T cells cytoplasmic calcineurin-dependent 3 (NFATc3; NFAT4); protein phosphatase 3 regulatory subunit B α (PPP3R1)
April 14, 2016 7:00 AM UTC
Patient sample and mouse studies suggest inhibiting NFATc3 or PPP3R1 could help treat colorectal cancer (CRC). In CRC patients, NFATc3 nuclear activity in tumor cells correlated with poor survival and...